Ready to peel back the layers of the medical universe and step into the world of renal cancer? We've got your ticket right here! Joined by urological surgeon, Dr Mark Lloyd, we journey into the intricacies of renal cancer.
In a riveting discussion, Dr Lloyd unveils the subgroups of renal cancer, the genetic marvel of the von Hippel Lindau gene, and targeted treatment, such as Sunitinib. Further, we familiarize ourselves with the TNM staging system, a crucial tool in determining the most beneficial treatment method for the patient.
As we dissect the treatment landscape for renal carcinoma, we encounter robotic surgery, whose precision goes beyond the grasp of the human hand. We tackle minimally invasive techniques like laparoscopic nephrectomy and robotic partial nephrectomy, used widely for treating renal tumors. Weighing in on focal therapy, an alternative route to surgical intervention, we discuss its effectiveness in small renal tumors and the types of tumors suitable for thermal treatments. So gear up for a roller coaster ride through the world of renal cancer!